Participants 65 121 4
postmenopausal patients with metastatic breast carcinoma
Participants 212 275 4
Breast cancer patients with prior response to endocrine therapy
Participants 642 669 6
683 postmenopausal patients
Participants 1703 1759 3
postmenopausal patients with metastatic breast carcinoma
